Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clindamycin/Benzoyl Peroxide Gel for Acne in Japanese Subjects
NCT01445301Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2011
- Primary completion
- Aug 2012
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of clindamycin + benzoyl peroxide in acne vulgaris (3 arms), sponsored by GSK. Primary endpoint: Absolute Change From Baseline in Total Lesion Counts at 12 weeks. Started Sep 2011; status: completed.
02
Drugs
clindamycin + benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01445301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01445301.